open access

Vol 11, Supp. G (2015)
Case report
Published online: 2017-12-17
Get Citation

Treatment with octreotide LAR of the advanced neuroendocrine neoplasm of the pancreas with liver metastases — a case report

Joanna Omyła-Staszewska

open access

Vol 11, Supp. G (2015)
CASE REPORT
Published online: 2017-12-17

Abstract

A most frequent malignant tumour of the pancreas is adenocarcinoma. The pancreas can be also a primary site of neuroendocrine neoplasms of the digestive system, which are a heterogeneous group of tumors derived from various neuroendocrine cells scattered within the gastrointestinal tract. These tumors can be secretory active. Production of hormones by neuroendocrine neoplasms are responsible for determined for the occurrence of characteristic clinical symptoms, what in many cases steers the diagnostics process and facilitates the earlier diagnosis. In case of secretary active neuroendocrine neoplasms of the pancreas clinical symptoms can depend from the secretion of the insulin, the gastrin, the glucagon, vasoactive peptide and etc. The current paper presents the case report of 45-years old patient with neuroendocrine tumour of the pancreas with liver metastases as an example confirming the effectiveness of somatostatin analogues in the control of clinical, radiological and bio­chemical syndromes and also an example of indicative of the necessity of the exercise of the echocardiography for the purpose of the exclusion of heart complications (carcinoid syndrome) in dumb clinically cases on the side of the cardiovascular system.

Abstract

A most frequent malignant tumour of the pancreas is adenocarcinoma. The pancreas can be also a primary site of neuroendocrine neoplasms of the digestive system, which are a heterogeneous group of tumors derived from various neuroendocrine cells scattered within the gastrointestinal tract. These tumors can be secretory active. Production of hormones by neuroendocrine neoplasms are responsible for determined for the occurrence of characteristic clinical symptoms, what in many cases steers the diagnostics process and facilitates the earlier diagnosis. In case of secretary active neuroendocrine neoplasms of the pancreas clinical symptoms can depend from the secretion of the insulin, the gastrin, the glucagon, vasoactive peptide and etc. The current paper presents the case report of 45-years old patient with neuroendocrine tumour of the pancreas with liver metastases as an example confirming the effectiveness of somatostatin analogues in the control of clinical, radiological and bio­chemical syndromes and also an example of indicative of the necessity of the exercise of the echocardiography for the purpose of the exclusion of heart complications (carcinoid syndrome) in dumb clinically cases on the side of the cardiovascular system.

Get Citation

Keywords

neuroendorcine neoplasms, GEP-NET, carcinoid syndrome, carcinoid heart disease, somatostatin analogues, octreotide LAR

About this article
Title

Treatment with octreotide LAR of the advanced neuroendocrine neoplasm of the pancreas with liver metastases — a case report

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. G (2015)

Article type

Case report

Pages

24-28

Published online

2017-12-17

Keywords

neuroendorcine neoplasms
GEP-NET
carcinoid syndrome
carcinoid heart disease
somatostatin analogues
octreotide LAR

Authors

Joanna Omyła-Staszewska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl